BIAF bioAffinity Technologies, Inc.

Nasdaq bioaffinitytech.com


$ 2.91 $ -0.47 (-13.78 %)    

Friday, 17-Oct-2025 19:25:36 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 2.94
$ 3.20
$ 2.86 x 100
$ 3.14 x 800
$ 2.94 - $ 3.22
$ 2.34 - $ 67.12
702,621
na
2.79M
$ 2.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-did-bioaffinity-technologies-stock-slip-in-after-hours-trading-after-a-big-day-of-gains

bioAffinity Technologies' stock surged after a patent notice and Nasdaq compliance update but slipped in after-hours trading.

 bioaffinity-technologies-gets-notification-of-allowance-from-united-states-patent-and-trademark-office-for-new-patent-covering-ai-built-algorithm-flow-cytometry-platform-to-detect-lung-cancer

SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company advancing e...

 whats-driving-bioaffinity-technologies-big-pre-market-surge

bioAffinity Technologies shares surged over 20% pre-market following a strong third-quarter sales update for its lung cancer di...

 bioaffinity-technologies-reports-sales-of-its-cypath-lung-diagnostic-test-for-lung-cancer-hit-record-high-in-q3-2025-marking-95-increase-over-the-previous-quarter

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)),a biotechnology company advancing noninvasive diagnostics for lung cancer ...

Core News & Articles

Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's...

 bioaffinity-technologies-prices-48m-public-offering-of-192m-shares-of-common-stock-or-pre-funded-warrants-at-a-price-of-250share

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)) a biotechnology company focused on the need for noninvasive tests for the ...

Core News & Articles

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

 why-merus-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus fo...

 nasdaq-gains-100-points-us-consumer-sentiment-falls

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow ...

 bioaffinity-stock-up-over-50-whats-driving-the-surge

Shares of bioAffinity Technologies Inc. (NASDAQ: BIAF) are trading higher Friday after the biotech company released case studie...

Core News & Articles

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

 dow-jumps-over-250-points-feds-key-inflation-gauge-remains-hot

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Friday. The Dow traded up 0...

Core News & Articles

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The ...

 bioaffinity-technologies-releases-three-additional-case-studies-one-case-study-includes-cypath-lung-detecting-stage-1a-lung-cancer

Noninvasive diagnostic test again leads to detecting Stage 1A lung cancer

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION